Barclays Capital Etf Profile
The performance scores are derived for the period starting the 17th of January 2025 and ending today, the 16th of February 2025. Click here to learn more.
Barclays Capital cannot be verified against its exchange. It appears that Barclays Capital is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
RefreshBarclays Etf Highlights
CEO, Director | Shai Cohen |
Old Name | CannaPowder Inc |
Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Logo U R L | imglogosUSCAPD.png |
Total Current Liabilities | 665,528 |
Total Stockholder Equity | (275,100) |
Currency Code | USD |
Fiscal Year End | December |
Begin Period Cash Flow | 606,245 |
Total Cashflows From Investing Activities | 196,337 |
Accounts Payable | 115,528 |
Retained Earnings | (6.34 Million) |
Cash | 205,205 |
50 Day M A | 22.2957 |
Code | CAPD |
Country Name | USA |
Net Interest Income | (5,583) |
Investments | 196,337 |
Other Current Assets | 37,775 |
Net Borrowings | 550,000 |
Total Liab | 665,528 |
Operating Income | (2.81 Million) |
Short Long Term Debt | 550,000 |
200 Day M A | 20.5411 |
Currencysymbol | USD |
Barclays Capital [CAPD] is traded in USA and was established 2012-10-10. The fund is listed under Health Care category and is part of Pharmaceuticals family. Barclays Capital currently have 281.77 K in assets under management (AUM). , while the total return for the last 3 years was 12.36%.
Barclays Capital currently holds about 205.21 K in cash with (1.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.02.
Check Barclays Capital Probability Of Bankruptcy
Barclays Capital Against Markets
Try Other Suggestions
Barclays Capital Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Barclays Capital etf to make a market-neutral strategy. Peer analysis of Barclays Capital could also be used in its relative valuation, which is a method of valuing Barclays Capital by comparing valuation metrics with similar companies.
Risk & Return | Correlation |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Tools for Barclays Etf
When running Barclays Capital's price analysis, check to measure Barclays Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barclays Capital is operating at the current time. Most of Barclays Capital's value examination focuses on studying past and present price action to predict the probability of Barclays Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barclays Capital's price. Additionally, you may evaluate how the addition of Barclays Capital to your portfolios can decrease your overall portfolio volatility.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |